title: The adverse effects of obesity on conception and implantation.
abstract: Whilst many multiparous women are obese (body mass index >30 kg/m(2)), obesity has been associated with impaired fecundity; however, the mechanism which links obesity to reduced fertility remains to be fully elucidated. Obese women, particularly those with central obesity, are less likely to conceive per cycle. Obese women suffer perturbations to the hypothalamic-pituitary-ovarian axis, menstrual cycle disturbance and are up to three times more likely to suffer oligo-/anovulation. A fine hormonal balance regulates follicular development and oocyte maturation, and it has been observed that obesity can alter the hormonal milieu. Leptin, a hormone produced by adipocytes, is elevated in obese women, and raised leptin has been associated with impaired fecundity. Obesity impairs ovulation but has also been observed to detrimentally affect endometrial development and implantation. The expression of polycystic ovary syndrome (PCOS) is regulated, in part, by weight, and so obese women with PCOS often have a more severe phenotype and experience more subfertility. Obesity also impairs the response of women to assisted conception treatments. Weight loss through lifestyle modification or bariatric surgery has been demonstrated to restore menstrual cyclicity and ovulation and improve the likelihood of conception. In this article, we will discuss the effect of obesity upon key reproductive mechanisms and its relation to fertility treatments.
authors.affiliation: The Leeds Centre for Reproductive Medicine, Seacroft Hospital, Leeds Teaching Hospitals NHS Trust, Leeds, LS14 6UH, UK.
authors.forename: Christopher J
authors.initials: CJ
authors.lastname: Brewer
authors.forename: Adam H
authors.initials: AH
authors.lastname: Balen
mesh_terms: D000273:Adipose Tissue / Q000378:metabolism / Q000503:physiopathology; D010064:Embryo Implantation; D005260:Female; D005306:Fertilization; D006728:Hormones / Q000378:metabolism; D006801:Humans; D007247:Infertility, Female / Q000209:etiology* / Q000378:metabolism / Q000503:physiopathology / Q000628:therapy; D008597:Menstrual Cycle / Q000378:metabolism; D009765:Obesity / Q000150:complications* / Q000378:metabolism / Q000503:physiopathology / Q000628:therapy; D009865:Oocytes / Q000378:metabolism; D010053:Ovary / Q000378:metabolism / Q000503:physiopathology; D011085:Polycystic Ovary Syndrome / Q000209:etiology / Q000503:physiopathology; D011247:Pregnancy; D027724:Reproductive Techniques, Assisted; D016896:Treatment Outcome; D014599:Uterus / Q000378:metabolism / Q000503:physiopathology; D015431:Weight Loss
chemical_list: D006728:Hormones